TREM2 and Parkinson disease: In order to control the involvement of autophagy in the pathogenesis of inflammation in PD, miR-3473b may affect TREM2/ULK1 expression, which suggests that it may be a possible therapeutic target to control the inflammatory response in PD (Lv et al., 2021).